A randomized phase III trial of second-line chemotherapy comparing CPT-11 alone versus S-1 plus CPT-11 combination therapy in advanced gastric cancer refractory to first-line therapy with S-1 (JACCRO GC-05)

被引：0

作者：

Nishikawa, Kazuhiro

Tanabe, Kazuaki

Fujii, Masashi

Kunisaki, Chikara

Tsuji, Akihito

Matsuhashi, Nobuhisa

Takagane, Akinori

Ohno, Tetsuro

Kawase, Tomono

Kochi, Mitsugu

Yoshida, Kazuhiro

Kakeji, Yoshihiro

Ichikawa, Wataru

Chin, Keisho

Terashima, Masanori

Takeuchi, Masahiro

Nakajima, Toshifusa

机构：

[1] Osaka Natl Hosp, Osaka, Japan

[2] Hiroshima Univ, Hiroshima, Japan

[3] Nihon Univ Sch Med, Tokyo, Japan

[4] Yokohama City Univ, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan

[5] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan

[6] Gifu Univ Sch Med, Gifu, Japan

[7] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan

[8] Gunma Univ Sch Med, Maebashi, Gunma, Japan

[9] Sakai City Hosp, Sakai, Osaka, Japan

[10] Gifu Univ Sch Med, Dept Surg Oncol, Gifu, Japan

[11] Kobe Univ, Dept Gastrointestinal Surg, Kobe, Hyogo 657, Japan

[12] Natl Def Med Coll Hosp, Tokorozawa, Saitama, Japan

[13] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[14] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan

[15] Kitasato Univ Sch Pharm, Tokyo, Japan

[16] Japan Clin Canc Res Org, Tokyo, Japan

来源：

关键词：

D O I：

10.1200/jco.2014.32.3_suppl.87

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1